Clinical Trials Browser

Phase 2 × cediranib × Lymphoid × Clear all

NCT00321724 2013-01-15

AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell